首页> 外文期刊>African Journal of Pharmacy and Pharmacology >The preliminary study of the mechanism and efficacy of non-steroidal anti-inflammatory drug treatment on nerve root type cervical spondylosis
【24h】

The preliminary study of the mechanism and efficacy of non-steroidal anti-inflammatory drug treatment on nerve root type cervical spondylosis

机译:非甾体类抗炎药治疗神经根型颈椎病的机理和疗效的初步研究

获取原文
           

摘要

This study aims to evaluate the cyclooxygenase-2 (COX-2) protein expression in spinal cord dorsal horn of rats with nerve root type cervical spondylosis (NRCS) and the clinical efficacy of different non-steroidal anti-inflammatory drugs (NSAIDs) treatment on Chinese patients with NRCS. 24 Sprague-Dawley (SD) rats were randomly divided into normal health group and NRCS model group, The COX-2 protein expression in spinal cord dorsal horn of rats was detected by immunohistochemical staining after administration. 52 NRCS patients were divided into celecoxib treatment group and diclofenac treatment group to compare the efficacy of different NSAIDs. The efficacy of NSAIDs on NRCS was assessed by visual analog scale (VAS) test. Compared with normal health group, the expressions of COX-2 protein in spinal cord dorsal horn increased significantly than in the NRCS model group. According to the results of VAS test, we found out that celecoxib is more effective than diclofenac sodium. Clinical drug therapy for NRCS can give priority to specific COX-2 inhibitors. Over expression of COX-2 might be a potential pathological mechanism of NRCS.
机译:本研究旨在评估神经根型颈椎病(NRCS)大鼠脊髓背角中环氧合酶2(COX-2)蛋白的表达,以及不同非甾体类抗炎药(NSAIDs)的临床疗效中国NRCS患者。将24只SD大鼠随机分为正常健康组和NRCS模型组,给药后通过免疫组织化学染色检测大鼠脊髓背角COX-2蛋白的表达。 52例NRCS患者分为塞来昔布治疗组和双氯芬酸治疗组,以比较不同NSAIDs的疗效。通过视觉模拟量表(VAS)测试评估了NSAIDs对NRCS的疗效。与正常对照组相比,脊髓背角COX-2蛋白的表达明显高于NRCS模型组。根据VAS测试的结果,我们发现塞来昔布比双氯芬酸钠更有效。 NRCS的临床药物治疗可以优先使用特定的COX-2抑制剂。 COX-2的过度表达可能是NRCS的潜在病理机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号